Zacks Investment Research Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Addex Therapeutics Ltd. Sponsored ADR (ADXN) been one of those stocks this...\n more…
Globe Newswire Geneva, Switzerland, September 4, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric...\n more…
Ticker Report Addex Therapeutics Ltd (NASDAQ:ADXN - Free Report) - Equities researchers at HC Wainwright dropped their FY2024 earnings estimates for shares of Addex Therapeutics in a note issued to investors on...\n more…
Ticker Report Addex Therapeutics Ltd (NASDAQ:ADXN - Free Report) - Stock analysts at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Addex Therapeutics in a research report...\n more…
Ticker Report HC Wainwright reaffirmed their buy rating on shares of Addex Therapeutics (NASDAQ:ADXN - Free Report) in a report released on Wednesday morning, Benzinga reports. They currently have a $30.00 price...\n more…
Benzinga U.S. stocks traded mostly lower midway through trading, with the Dow Jones index falling around 0.2% on Tuesday. The Dow traded down 0.16% to 41,175.13 while the NASDAQ fell 0.03% to 17,720.68. The S&P 500 also fell, dropping, 0.01% to 5,616.66.\n more…